Navigation Links
Varian Medical Systems to Offer CIVCO Medical Solutions' Body Pro-Lok™ for SBRT
Date:7/29/2011

KALONA, Iowa, July 29, 2011 /PRNewswire/ -- CIVCO is pleased to announce the signing of a reseller agreement that would allow Varian Medical Systems to offer CIVCO's Body Pro-Lok to its customers. Introduced in 2008 and installed at over 150 community and academic facilities worldwide, Body Pro-Lok excels as a modular base for indexable patient positioning, secure immobilization and efficient patient transport.

(Logo: http://photos.prnewswire.com/prnh/20110419/AQ85801LOGO)

Body Pro-Lok was designed to maximize patient comfort during immobilization for treatment.  Niko Papanikolaou, Ph.D, Chief of the Division Medical Physics at UT San Antonio's Cancer Therapy & Research Center, has worked extensively with the Body Pro-Lok immobilization product. "The Body Pro-Lok system is very effective for SBRT respiration immobilization," said Papanikolaou. "It is highly indexed, provides setup reproducibility and it is an easy and efficient device to use for robust immobilization."

When used with CIVCO's Protura Robotic Patient Positioning System and Universal Couchtop, Body Pro-Lok is part of a complete motion management solution. Protura and Universal Couchtop have been validated with Varian's Clinac® and Trilogy® platforms.  Body Pro-Lok is available worldwide through CIVCO's account representatives, and now also through Varian's sales channels.

About CIVCOCIVCO Medical Solutions has over 30 years of experience and offers cutting-edge medical technology to a diverse group of medical professionals. The Multi-Modality Imaging (MMI) unit designs and manufactures accessories for use in diagnostic and therapeutic imaging and interventional procedures, with a strong focus on ultrasound. MMI's products range from infection control products including a wide range of ultrasound and CT covers to device guidance, positioning and electromagnetic needle tracking. CIVCO's Radiation Oncology division designs and manufactures products for radiation oncology treatment, including basic patient positioning equipment as well as high technology robotic motion management and advanced patient positioning for SBRT. CIVCO offers patients and clinicians the newest and best technology available to improve patient care.

Corporate information is available at www.CIVCO.com. Media Contact:AAPM In-Booth Contact:Liz Etchells

Jennifer TobinMarketing Communications Specialist

Trade Show CoordinatorPhone: 319-248-6551

Mobile: 631-903-4084Mobile: 319-541-9672

AAPM Booth #817Email: liz.etchells@civco.comCOPYRIGHT © 2011. CIVCO IS A REGISTERED TRADEMARK OF CIVCO MEDICAL SOLUTIONS. BODY PRO-LOK AND LASER-LOK ARE TRADEMARKS OF CIVCO. ALL PRODUCTS MAY NOT BE LICENSED IN ACCORDANCE WITH CANADIAN LAW. 2011C-0687


'/>"/>

SOURCE CIVCO Medical Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
(Date:8/2/2017)... 2017   Marshall County Hospital in Benton, Kentucky has ... of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ... pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics , ... Dallas, Texas , has received notice from the ... Institutes of Health (NIH) that it has been awarded ... totaling over $650,000 in 2017 with an additional $1,000,000 ... Investigational New Drug application of their lead non-opioid drug ...
Breaking Medicine Technology:
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... Greenfield Advisors ... companies in the U.S. for the second year in a row. The Inc. 5000 ... past three years. , “To be on the list once is a great accomplishment, ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second year, ... student to educate the public on the impact of concussions. Brooke Mills, student ... National Concussion Awareness Day. , Brooke is working diligently is to raise awareness ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... of their recently launched community enrichment program. Partnering once again with Boys & ... Superstar competition to help find the area’s very own American Idol. With all ...
(Date:8/16/2017)... ... August 16, 2017 , ... LabRoots , the ... from around the world, is excited to announce Andrew Ly as the winner of ... pursuits, covering textbook costs. , Ly, who is in his third year at ...
(Date:8/16/2017)... ... August 16, 2017 , ... Melbourne’s reign as the world’s most liveable city ... (EIU) annual Liveability Index. , The Index surveys 140 of the world’s cities and ... Melbourne has consistently come in the top three of the index. So what is ...
Breaking Medicine News(10 mins):